complement system screen compl 300 kits (Euro Diagnostica)
90
Structured Review
Euro Diagnostica
complement system screen compl 300 kits
Complement System Screen Compl 300 Kits, supplied by Euro Diagnostica, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement+functional+screen+elisa+kit/wieslab+complement+system+screen/pmc05217898-456-0-12
Average 90 stars, based on 1 article reviews
Complement System Screen Compl 300 Kits, supplied by Euro Diagnostica, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement+functional+screen+elisa+kit/wieslab+complement+system+screen/pmc05217898-456-0-12
Average 90 stars, based on 1 article reviews
complement system screen compl 300 kits - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders Article Snippet: The Article Title: Real-Life Comparison of Four JAK Inhibitors in Rheumatoid Arthritis (ELECTRA- i Study) Article Snippet: Furthermore, the following parameters were evaluated at baseline and after 3, 6, and 12 months: ESR (Alifax, Padova, Italy) and CRP levels (Unicel Coulter DxC 800 Synchron Central System; Beckman Coulter Inc, Brea, CA, USA); Anti-Citrullinated Peptide Antibodies (ACPAs) (EliA CCP; Phadia AB, Uppsala, Sweden); rheumatoid factor (RF) IgM (N Latex RF; Siemens AG, Munich, Germany); hematological inflammatory indices (neutrophils/lymphocytes (N/L), monocytes/lymphocytes (M/L), platelets/lymphocytes (P/L)) [ ]; circulating calprotectin (Eurospital, Trieste, Italy); soluble urokinase plasminogen activator receptor (suPAR) (CHORUS suPAR; Diesse Diagnostica Senese SpA, Monteriggioni, Italy); determination of functional classical, MBL, and alternative complement pathways (WIESLAB ® Complement system Screen, Euro Diagnostica AB, Malmö, Sweden); circulating cytokines TNFα (Human TNF-alpha Quantikine Immunoassay; R&D Systems Inc., Minneapolis, MN, USA), IL-6 (Human IL-6 Instant Enzyme-linked Immunosorbent assay; eBioscience, Bender MedSystem GmbH, Vienna, Austria), CD3 + , CD3 + CD4 + , CD3 + CD8 + , CD3 + CD4 + /CD3 + CD8 + , CD19 + , and NKCD3 − /CD56 + CD16 + ; and lymphocyte percentages and absolute counts in peripheral whole blood (BD FACS Canto II flow cytometer; Biosciences, San Jose, CA, USA). Activity Assay:Article Title: Survival of Borrelia burgdorferi Strain B31 in Human Serum Is Not Dependent on C4BP Binding to the Bacterial Surface Article Snippet: .. The retained complement activity in the depleted serum and control serum was verified by erythrocyte lysis assay as previously described [11] (Supplementary Figure S6) and WIESLAB Article Title: Anti-complement factor Bb antibodies and uses thereof Article Snippet: .. Purified mAbs were further screened for inhibition of alternative pathway (AP) activity using the Article Title: Survival of Borrelia burgdorferi Strain B31 in Human Serum Is Not Dependent on C4BP Binding to the Bacterial Surface Article Snippet: .. The retained complement activity in the depleted serum and control serum was verified by erythrocyte lysis assay as previously described [ ] ( ) and WIESLAB Article Title: Atypical Hemolytic Uremic Syndrome Associated with BNT162b2 mRNA COVID-19 Vaccine in a Kidney Transplant Recipient: A Case Report and Literature Review. Article Snippet: .. The TMA investigation included analysis of serum complement levels (including CH50 and AP50), performed using the Article Title: Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders Article Snippet: Experiment #3: Wieslab Complement Assays with 3MC Patient Sera Methods: Sera obtained from 3MC patient #2 (MASP-3 (−/−), MASP-1 (+/+)) and from 3MC patient #3 (MASP-3 (−/−), MASP-1 (−/−)) were also tested for classical, lectin and alternative pathway activity using the Wieslab Complement System Screen (Euro-Diagnostica, Malmö, Sweden) according to the manufacturer's instructions. .. Experiment #3: Wieslab Complement Assays with 3MC Patient Sera Methods: Sera obtained from 3MC patient #2 (MASP-3 (−/−), MASP-1 (+/+)) and from 3MC patient #3 (MASP-3 (−/−), MASP-1 (−/−)) were also tested for classical, lectin and alternative pathway activity using the Article Title: CG001, a C3b-targeted complement inhibitor, blocks 3 complement pathways: development and preclinical evaluation Article Snippet: Measurement of in vitro complement activity All complement inhibitory assays were performed in Wieslab Complement System Kit except where specified. .. The Control:Article Title: Survival of Borrelia burgdorferi Strain B31 in Human Serum Is Not Dependent on C4BP Binding to the Bacterial Surface Article Snippet: .. The retained complement activity in the depleted serum and control serum was verified by erythrocyte lysis assay as previously described [11] (Supplementary Figure S6) and WIESLAB Article Title: Survival of Borrelia burgdorferi Strain B31 in Human Serum Is Not Dependent on C4BP Binding to the Bacterial Surface Article Snippet: .. The retained complement activity in the depleted serum and control serum was verified by erythrocyte lysis assay as previously described [ ] ( ) and WIESLAB Lysis:Article Title: Survival of Borrelia burgdorferi Strain B31 in Human Serum Is Not Dependent on C4BP Binding to the Bacterial Surface Article Snippet: .. The retained complement activity in the depleted serum and control serum was verified by erythrocyte lysis assay as previously described [11] (Supplementary Figure S6) and WIESLAB Article Title: Survival of Borrelia burgdorferi Strain B31 in Human Serum Is Not Dependent on C4BP Binding to the Bacterial Surface Article Snippet: .. The retained complement activity in the depleted serum and control serum was verified by erythrocyte lysis assay as previously described [ ] ( ) and WIESLAB Enzyme-linked Immunosorbent Assay:Article Title: Survival of Borrelia burgdorferi Strain B31 in Human Serum Is Not Dependent on C4BP Binding to the Bacterial Surface Article Snippet: .. The retained complement activity in the depleted serum and control serum was verified by erythrocyte lysis assay as previously described [11] (Supplementary Figure S6) and WIESLAB Article Title: Survival of Borrelia burgdorferi Strain B31 in Human Serum Is Not Dependent on C4BP Binding to the Bacterial Surface Article Snippet: .. The retained complement activity in the depleted serum and control serum was verified by erythrocyte lysis assay as previously described [ ] ( ) and WIESLAB Article Title: CG001, a C3b-targeted complement inhibitor, blocks 3 complement pathways: development and preclinical evaluation Article Snippet: Measurement of in vitro complement activity All complement inhibitory assays were performed in Wieslab Complement System Kit except where specified. .. The Purification:Article Title: Anti-complement factor Bb antibodies and uses thereof Article Snippet: .. Purified mAbs were further screened for inhibition of alternative pathway (AP) activity using the Inhibition:Article Title: Anti-complement factor Bb antibodies and uses thereof Article Snippet: .. Purified mAbs were further screened for inhibition of alternative pathway (AP) activity using the Functional Assay:Article Title: CG001, a C3b-targeted complement inhibitor, blocks 3 complement pathways: development and preclinical evaluation Article Snippet: Measurement of in vitro complement activity All complement inhibitory assays were performed in Wieslab Complement System Kit except where specified. .. The |